Literature DB >> 16575092

Preventing coronary heart disease: high baseline risk strategy and cost effectiveness of guidelines.

D Graham Mackenzie, John Forbes, Sarah Wild, Philip Rutledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16575092      PMCID： PMC1420769          DOI： 10.1136/bmj.332.7544.793

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

Authors:  J M Wright; C H Lee; G K Chambers
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

Review 2.  Revisiting Rose: strategies for reducing coronary heart disease.

Authors:  Douglas G Manuel; Jenny Lim; Peter Tanuseputro; Geoffrey M Anderson; David A Alter; Andreas Laupacis; Cameron A Mustard
Journal:  BMJ       Date:  2006-03-18

3.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Authors:  Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.